Yes if only 24 weeks for pivotal then it will not be far behind combo. That would be great!! Even if it ends up being 48 weeks that won’t be too much later (much sooner than A17 Survivor or Fine will ever admit. I know protocol and enrollment will take some time as ohm or steelpharm mentioned (I respect their opinions more than most) so I am not getting my hopes up yet on mono. Actually other than a salvage valuation for leronlimab I quit factoring in HIV revenues at all as I am that confident in cancer being successful.


Cash is critical now, so we need some upfront payments to get a decent valuation until revenue begins.